CAMBRIDGE, Mass., May 31 /PRNewswire/ -- ETEX Corporation today
announced that Brian T. Ennis has been appointed as the Company's new
President and Chief Executive Officer, effective May 29, 2007.
Mr. Ennis has more than 25 years of medical device sales, marketing and
executive management experience in both domestic and international markets.
Prior to joining ETEX, Mr. Ennis served as President of Empi, Inc., a
subsidiary of Encore Medical Corporation; before that he served as
President of International at Wright Medical Group. Mr. Ennis also served
at Stryker Corporation for 11 years in a variety of domestic and
international marketing and general management roles.
"We are extremely excited to have Brian join our talented team. Brian
has the experience, track record and skills to lead the company's
biomaterials technology expansion and commercialization efforts in the
market-driving areas of skeletal repair and regeneration," commented
ChinKyu Huh, ETEX's Chairman of the Board.
Brian Ennis commented "It is a privilege to join the ETEX family. ETEX
has tremendous upside due to their established and potential strategic
partnerships and their proven technology. Products in development have
great potential to improve clinical outcomes in a broad range of
applications including spine, general orthopedics, neurosurgery,
interventional radiology, and sports medicine."
ETEX Corporation develops, manufactures and commercializes proprietary
calcium phosphate based biomaterials for skeletal repair and regeneration.
The Company is focused on expanding applications for its proprietary
bioresorbable materials technology through combination with cells,
biologics, or therapeutic agents delivered in minimally invasive, easy to
use systems.
For more information, please visit http://www.etexcorp.com .
SOURCE ETEX Corporation
 back to top
Related links:
http://www.etexcorp.com
CONTACT:
Steve Kim of ETEX Corporation, Chief
Financial Officer, +1-617- 577-7270
|
